Great Point Partners LLC Glaukos Corp Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$48.9 - $75.26 $21.8 Million - $33.6 Million
-446,097 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$37.23 - $50.97 $2.01 Million - $2.75 Million
-53,903 Reduced 10.78%
446,097 $22.1 Million
Q2 2020

Aug 14, 2020
BUY
$28.78 - $46.83 $14.4 Million - $23.4 Million
500,000 New
500,000 $19.2 Million

Others Institutions Holding GKOS

# of Institutions
340
Shares Held
47.1M
Call Options Held
132K
Put Options Held
188K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.73B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email